Validation Data Gallery
Tested Applications
Positive WB detected in | HeLa cells, mouse brain tissue, rat brain tissue |
Positive IF/ICC detected in | HeLa cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
32204-1-AP targets DNAJC5 in WB, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | DNAJC5 fusion protein Ag35443 相同性解析による交差性が予測される生物種 |
Full Name | DnaJ (Hsp40) homolog, subfamily C, member 5 |
Calculated molecular weight | 22kDa,198aa |
Observed molecular weight | 30 kDa |
GenBank accession number | NM_025219.2 |
Gene Symbol | DNAJC5 |
Gene ID (NCBI) | 80331 |
RRID | AB_3670222 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity Purification |
UNIPROT ID | Q9H3Z4 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
DNAJC5 (DnaJ homolog subfamily C member 5), also known as cysteine string protein α (CSPα), is a member of the HSP40 (DNAJ) family of proteins, as well as a co-chaperone of HSC70, and has been shown to control the extracellular release of many neurodegenerative disease proteins. DNAJC5 contains three structural domains - -a common N-terminal J structural domain conserved in DNAJ proteins, the cysteine string (CS) central structural domain, which is highly palmitoylated and anchors the protein to late endosomes, and an overall disordered C-terminal structural domain. Mutations in DNAJC5 have been strongly implicated in the development of human diseases such as neuronal waxy lipofuscinosis, cystic fibrosis, Huntington's disease and Parkinson's disease.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for DNAJC5 antibody 32204-1-AP | Download protocol |
IF protocol for DNAJC5 antibody 32204-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |